GE HealthCare stock eases after modest Nasdaq decline

Published on 09/16/2026 at 15:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

GE HealthCare stock closed at USD 64.07 on Nasdaq on September 15, 2026, down 0.3 percent as broader indices also softened. The shares traded 4.26 million units and ended the day just under the intraday high in a tight range.

Techniker bedient MRT-Scanner in hellem Krankenhaus-Untersuchungsraum mit Flurblick — GE HealthCare US36266G1076 zeigt einen modernen MRT-Scanner im hellen klinischen Krankenhaus mit Techniker, Illustration mit AI erstellt.

GE HealthCare Technologies Inc. (ISIN US36266G1076) stock closed at USD 64.07 on the Nasdaq on September 15, 2026, marking a 0.3 percent decline from the prior session as the broader Nasdaq Composite also moved lower.ad hoc news reported that the shares traded within a narrow intraday band and finished the day just below the session high, underscoring a cautious tone around the stock ahead of the next catalysts.

Recent trading and market context

According to ad hoc news, GE HealthCare stock traded in a range of USD 63.88 to USD 64.64 on September 15, 2026, with the closing price sitting about 0.9 percent below the intraday high, indicating limited upside momentum during the session.

The same report cited an exchange volume of 4,260,000 shares for GE HealthCare on Nasdaq on September 15, 2026, compared with after-hours volume of 159,160 shares recorded later that evening, showing that most activity remained concentrated during regular trading hours.ad hoc news also highlighted that the share price move came as the Nasdaq Composite fell 0.6 percent to 26,186.41, suggesting that the stock’s modest 0.3 percent decline was broadly in line with the index.

Analyst stance and implied expectations

Fresh analyst data compiled on September 16, 2026, show that GE HealthCare stock carries an average target price of USD 82.50 based on selected coverage, compared with a current level of USD 64.07, pointing to a gap of roughly 28.7 percent between the prevailing price and the average target.Yahoo Finance lists an analyst target range from USD 70.00 on the lower end to USD 96.00 on the upper end, reflecting differing views on the company’s earnings trajectory and risk profile.

As of August 19, 2026, BTIG reiterated a Buy rating on GE HealthCare with a maintained price target of USD 79.00, signaling continued conviction that the shares offer upside from the current trading band.Yahoo Finance places this call in the context of an overall recommendation mix that includes Strong Buy, Buy, Hold, Underperform and Sell, with the recent data suggesting a tilt toward more positive ratings.

Ownership moves as an additional signal

Institutional positioning offers another perspective on GE HealthCare stock. On September 15, 2026, a filing overview noted that California State Teachers Retirement System had adjusted its stake in GE HealthCare Technologies Inc., reflecting ongoing portfolio management by large, long-horizon investors.MarketBeat aggregates data showing that a mix of institutional investors have been active in the stock, which can influence liquidity and volatility around reporting dates.

The same MarketBeat snapshot recaps research coverage indicating that several firms have placed GE HealthCare in the Hold to Buy range, with an average rating categorized as Hold and an average target price of USD 77.73 at the time of its compilation.MarketBeat notes that ten analysts have assigned a Buy rating and eleven have issued a Hold rating, giving investors a nuanced view of how the market interprets the company’s fundamentals.

Stock level in relation to targets

With GE HealthCare stock at USD 64.07 as of September 15, 2026, investors can compare this level with the average target of USD 82.50 cited in recent analyst summaries, which implies that the stock trades below the consensus valuation range by more than one-fifth.Yahoo Finance data also show the current price below the lower bound of USD 70.00 in some target bands, an indication that a portion of the market sees room for a rerating if forthcoming quarterly results or guidance justify it.

At the same time, the MarketBeat-derived average target of USD 77.73 sits between the current trading price and the more ambitious upper targets, suggesting that, on this measure, the implied upside from USD 64.07 would be around 21.4 percent if the stock were to move toward that mid-range estimate.MarketBeat positions this within a context where the average rating remains Hold, indicating neither a clear consensus for aggressive buying nor for exiting the position.

Closing price snapshot

GE HealthCare stock is referenced at a closing price of USD 64.07 on Nasdaq as of September 15, 2026, with a daily move of minus 0.3 percent from the previous close, and the intraday range of USD 63.88 to USD 64.64 places the stock just under its session high in a relatively tight band.ad hoc news notes that the move occurred alongside a 0.6 percent decline in the Nasdaq Composite, situating the stock’s performance within the broader risk-off tone in US equities.